CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. by Komdeur, F, Prins, T, van de Wall, S, Plat, A, Wisman, G, Hollema, H, Daemen, T, Church, D, de Bruyn, M, Nijman, H

Design, synthesis, and biological evaluation of 2-hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 antagonist and its comparison to available small molecular PD-L1 inhibitors by Ważyńska, MA, Butera, R, Requesens, M, Plat, A, Zarganis-Tzitzikas, T, Neochoritis, CG, Plewka, J, Skalniak, L, Kocik-Krol, J, Musielak, B, Magiera-Mularz, K, Rodriguez, I, Blok, SN, de Bruyn, M, Nijman, HW, Elsinga, PH, Holak, TA, Dömling, A

A transcriptionally distinct CXCL13+ CD103+ CD8+ T-cell population is associated with B-cell 2 recruitment and neoantigen load in human cancer by Workel, H, Lubbers, J, Arnold, R, Prins, T, Van Der Vlies, P, De Lange, K, Bosse, T, Van Gool, I, Eggink, F, Wouters, M, Komdeur, F, Creutzberg, C, Kol, A, Plat, A, Glaire, M, Church, D, Nijman, H, De Bruyn, M

Prognostic integrated image-based immune and molecular profiling in early-stage endometrial cancer by Horeweg, N, de Bruyn, M, Nout, RA, Stelloo, E, Kedzierska, KZ, León-Castillo, A, Plat, A, Mertz, KD, Osse, M, Jürgenliemk-Schulz, IM, Lutgens, LC, Jobsen, JJ, van der Steen-Banasik, EM, Smit, VTHBM, Creutzberg, CL, Bosse, T, Nijman, HW, Koelzer, VH, Church, DN

Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study by Eerkens, AL, Brummel, K, Vledder, A, Paijens, ST, Requesens, M, Loiero, D, van Rooij, N, Plat, A, Haan, F, Klok, P, Yigit, R, Roelofsen, T, de Lange, NM, Klomp, R, Church, D, ter Elst, A, Wardenaar, R, Spierings, D, Foijer, F, Koelzer, VH, Bosse, T, Bart, J, Jalving, M, Reyners, AKL